These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11674965)

  • 1. [IFN-induced anosmia y ageusia in chronic hepatitis C].
    Manzano Alonso ML; Muñoz Gómez R; Castellano Tortajada G; Solis Herruzo JA
    Gastroenterol Hepatol; 2001 Oct; 24(8):412. PubMed ID: 11674965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anosmia secondary to treatment with interferon in a patient with chronic hepatitis C].
    Fernández Fernández FJ; Castiella Eguzkiza A; Tejada Calabia AM; García Bengoechea M
    Gastroenterol Hepatol; 2000 Dec; 23(10):499-500. PubMed ID: 11149229
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-induced anosmia in a patient with chronic hepatitis C.
    Maruyama S; Hirayama C; Kadowaki Y; Sagayama A; Omura H; Nakamoto M
    Am J Gastroenterol; 1998 Jan; 93(1):122-3. PubMed ID: 9448193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
    Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
    Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
    [No Abstract]   [Full Text] [Related]  

  • 5. Anosmia induced with alpha interferon in a patient with chronic hepatitis C.
    Kraus I; Vitezic D
    Int J Clin Pharmacol Ther; 2000 Jul; 38(7):360-1. PubMed ID: 10919345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Convulsive seizure during a treatment with interferon alpha for chronic viral hepatitis C].
    Verger P; De Monredon J; Blais J
    Gastroenterol Clin Biol; 1997; 21(11):902-3. PubMed ID: 9587549
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
    Papaioannides D; Fotinou M; Korantzopoulos P; Latsi P; Sinapidis D; Akritidis N; Orphanidou D
    Med Sci Monit; 2004 Jan; 10(1):CS5-7. PubMed ID: 14704637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioedema after interferon therapy for chronic hepatitis C.
    Ohmoto K; Yamamoto S
    Am J Gastroenterol; 2001 Apr; 96(4):1311-2. PubMed ID: 11316204
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
    Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
    Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyarteritis nodosa after interferon treatment for chronic hepatitis C.
    de Dios García-Díaz J; García-Sánchez M; Busteros JI; Arcos P
    J Clin Virol; 2005 Feb; 32(2):181-2. PubMed ID: 15653424
    [No Abstract]   [Full Text] [Related]  

  • 13. Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy.
    Cedar MA; Zancosky KL; Oliva LA; Molloy PJ; Weissgold DJ; Krawitt EL
    Am J Gastroenterol; 2007 Nov; 102(11):2612-3. PubMed ID: 17958775
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

  • 15. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N; Aykin N; Demirdal T; Cevik F
    Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C.
    Tahan V; Tahan G; Dane F; Uraz S; Yardim M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):224-5. PubMed ID: 17592576
    [No Abstract]   [Full Text] [Related]  

  • 17. Guess what! Tinea manus during interferon-alpha therapy for chronic hepatitis C.
    Koga T; Shimizu A; Kubota Y; Nakayama J; Sohda T
    Eur J Dermatol; 2000; 10(7):565-6. PubMed ID: 11056434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pulmonary sarcoidosis--a rare complication of interferon treatment for chronic hepatitis C].
    Pellová A; Pella J; Schréter I; Somos A; Kristian P; Boom A
    Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):200-2. PubMed ID: 17080355
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C.
    Gabrielli M; Santarelli L; Serricchio M; Leo D; Pola P; Gasbarrini A
    Am J Gastroenterol; 2003 Apr; 98(4):940. PubMed ID: 12738487
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ribavirin/interferon-induced anemia with erythropoietin in patients with hepatitis C.
    Gergely AE; Lafarge P; Fouchard-Hubert I; Lunel-Fabiani F
    Hepatology; 2002 May; 35(5):1281-2. PubMed ID: 11981781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.